Logo image of SNDA

SONIDA SENIOR LIVING INC (SNDA) Stock Fundamental Analysis

USA - NYSE:SNDA - US1404752032 - Common Stock

26.38 USD
-0.28 (-1.05%)
Last: 10/6/2025, 4:15:01 PM
26.38 USD
0 (0%)
After Hours: 10/6/2025, 4:15:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SNDA. SNDA was compared to 101 industry peers in the Health Care Providers & Services industry. SNDA may be in some trouble as it scores bad on both profitability and health. SNDA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SNDA has reported negative net income.
SNDA had a positive operating cash flow in the past year.
SNDA had negative earnings in 4 of the past 5 years.
SNDA had negative operating cash flow in 4 of the past 5 years.
SNDA Yearly Net Income VS EBIT VS OCF VS FCFSNDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

SNDA has a worse Return On Assets (-4.59%) than 68.32% of its industry peers.
SNDA has a Return On Equity of -36.12%. This is in the lower half of the industry: SNDA underperforms 71.29% of its industry peers.
Industry RankSector Rank
ROA -4.59%
ROE -36.12%
ROIC N/A
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNDA Yearly ROA, ROE, ROICSNDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SNDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SNDA Yearly Profit, Operating, Gross MarginsSNDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

SNDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SNDA has been increased compared to 1 year ago.
Compared to 5 years ago, SNDA has more shares outstanding
Compared to 1 year ago, SNDA has an improved debt to assets ratio.
SNDA Yearly Shares OutstandingSNDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SNDA Yearly Total Debt VS Total AssetsSNDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.03, we must say that SNDA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.03, SNDA is doing worse than 78.22% of the companies in the same industry.
SNDA has a Debt/Equity ratio of 6.12. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of SNDA (6.12) is worse than 81.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.12
Debt/FCF N/A
Altman-Z 0.03
ROIC/WACCN/A
WACC8.46%
SNDA Yearly LT Debt VS Equity VS FCFSNDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.85 indicates that SNDA may have some problems paying its short term obligations.
With a Current ratio value of 0.85, SNDA is not doing good in the industry: 83.17% of the companies in the same industry are doing better.
A Quick Ratio of 0.85 indicates that SNDA may have some problems paying its short term obligations.
SNDA's Quick ratio of 0.85 is on the low side compared to the rest of the industry. SNDA is outperformed by 74.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
SNDA Yearly Current Assets VS Current LiabilitesSNDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.60% over the past year.
The Revenue has been growing slightly by 4.96% in the past year.
SNDA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.41% yearly.
EPS 1Y (TTM)57.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.4%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%18.19%

3.2 Future

SNDA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.45% yearly.
The Revenue is expected to grow by 12.60% on average over the next years. This is quite good.
EPS Next Y17.59%
EPS Next 2Y3.5%
EPS Next 3Y5.45%
EPS Next 5YN/A
Revenue Next Year27.28%
Revenue Next 2Y16.25%
Revenue Next 3Y12.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNDA Yearly Revenue VS EstimatesSNDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
SNDA Yearly EPS VS EstimatesSNDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SNDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNDA Price Earnings VS Forward Price EarningsSNDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNDA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.37
SNDA Per share dataSNDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.5%
EPS Next 3Y5.45%

More info and screens

0

5. Dividend

5.1 Amount

SNDA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONIDA SENIOR LIVING INC

NYSE:SNDA (10/6/2025, 4:15:01 PM)

After market: 26.38 0 (0%)

26.38

-0.28 (-1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-11 2025-08-11/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners82.2%
Inst Owner Change0%
Ins Owners19.1%
Ins Owner Change3.21%
Market Cap496.47M
Analysts43.33
Price Target26.52 (0.53%)
Short Float %1.93%
Short Ratio13.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.21
Dividend Growth(5Y)N/A
DP-14.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.21%
Min EPS beat(2)20.54%
Max EPS beat(2)79.89%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)1.32%
EPS NQ rev (3m)1.32%
EPS NY rev (1m)20.26%
EPS NY rev (3m)20.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.41
P/FCF N/A
P/OCF 39.42
P/B 4.6
P/tB 5.88
EV/EBITDA 32.37
EPS(TTM)-2.4
EYN/A
EPS(NY)-2.8
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)0.67
OCFY2.54%
SpS18.71
BVpS5.74
TBVpS4.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.59%
ROE -36.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 6.12
Debt/FCF N/A
Debt/EBITDA 18.33
Cap/Depr 59.55%
Cap/Sales 8.69%
Interest Coverage N/A
Cash Conversion 34.97%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z 0.03
F-Score4
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)55.33%
Cap/Depr(5y)43.9%
Cap/Sales(3y)8.53%
Cap/Sales(5y)6.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.4%
EPS Next Y17.59%
EPS Next 2Y3.5%
EPS Next 3Y5.45%
EPS Next 5YN/A
Revenue 1Y (TTM)4.96%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%18.19%
Revenue Next Year27.28%
Revenue Next 2Y16.25%
Revenue Next 3Y12.6%
Revenue Next 5YN/A
EBIT growth 1Y-37.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year676.24%
EBIT Next 3Y112.63%
EBIT Next 5YN/A
FCF growth 1Y-5.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y150.41%
OCF growth 3YN/A
OCF growth 5YN/A